Tex. Health and Safety Code § 490.051
PATIENT ELIGIBILITY
Texas · Texas Health and Safety Code · Status: effective
Cite this
- Citation
- Tex. Health and Safety Code § 490.051, PATIENT ELIGIBILITY, Texas, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/674104
- Permanent ID
ys:prov:674104@1- SHA-256
4c2607db77a99275550d2ce8cb131c4f76c944b7b8ce179d46584370f4f21be0
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
A patient is eligible to access and use an investigational drug, biological product, or device under this chapter if:
(1) the patient has a severe chronic disease the commissioner designates under Section 490.002 that the patient's treating physician confirms in writing;
(2) the use of the investigational drug, biological product, or device is consistent with this chapter and rules adopted under this chapter; and
(3) the patient's physician:
(A) in consultation with the patient, considers all other treatment options the United States Food and Drug Administration has currently approved and determines those treatment options are unavailable or unlikely to provide relief for the significant impairment or severe pain associated with the patient's severe chronic disease; and
(B) recommends or prescribes in writing the patient's use of a specific class of investigational drug, biological product, or device.